149 related articles for article (PubMed ID: 26540277)
21. EVOLUTION OF VIEWS ON THE PATHOGENESIS OF INFLAMMATORY BOWEL DISEASE.
Sizyakina LP; Tarasova GN; Dobaeva NV
Eksp Klin Gastroenterol; 2016; (8):57-61. PubMed ID: 29874437
[TBL] [Abstract][Full Text] [Related]
22. Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense.
Farache J; Zigmond E; Shakhar G; Jung S
Immunol Cell Biol; 2013 Mar; 91(3):232-9. PubMed ID: 23399695
[TBL] [Abstract][Full Text] [Related]
23. Innate immune responses to commensal bacteria in the gut epithelium.
Vaishnava S; Behrendt CL; Hooper LV
J Pediatr Gastroenterol Nutr; 2008 Apr; 46 Suppl 1():E10-1. PubMed ID: 18354312
[No Abstract] [Full Text] [Related]
24. Innate lymphocytes induce inflammatory bowel disease.
Diefenbach A; Vonarbourg C
Immunol Cell Biol; 2010 Oct; 88(7):694-6. PubMed ID: 20585336
[No Abstract] [Full Text] [Related]
25. Regulatory cell populations in the intestinal mucosa.
Goodman WA; Pizarro TT
Curr Opin Gastroenterol; 2013 Nov; 29(6):614-20. PubMed ID: 24100716
[TBL] [Abstract][Full Text] [Related]
26. [Innate immunity and inflammatory bowel diseases].
Kinoshita M; Takeda K
Arerugi; 2012 Dec; 61(12):1726-8. PubMed ID: 23466613
[No Abstract] [Full Text] [Related]
27. Immunology of inflammatory bowel disease and molecular targets for biologics.
Dave M; Papadakis KA; Faubion WA
Gastroenterol Clin North Am; 2014 Sep; 43(3):405-24. PubMed ID: 25110250
[TBL] [Abstract][Full Text] [Related]
28. Immunopathology of the gastrointestinal system. Introduction.
Kagnoff MF
Springer Semin Immunopathol; 2005 Sep; 27(2):129-31. PubMed ID: 16059722
[No Abstract] [Full Text] [Related]
29. Inflammatory bowel disease.
Abraham C; Cho JH
N Engl J Med; 2009 Nov; 361(21):2066-78. PubMed ID: 19923578
[No Abstract] [Full Text] [Related]
30. Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease.
Zhou GX; Liu ZJ
J Dig Dis; 2017 Sep; 18(9):495-503. PubMed ID: 28857501
[TBL] [Abstract][Full Text] [Related]
31. Role of the innate immune system in the pathogenesis of inflammatory bowel disease.
van Lierop PP; Samsom JN; Escher JC; Nieuwenhuis EE
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):142-51. PubMed ID: 19179875
[TBL] [Abstract][Full Text] [Related]
32. [Innate and acquired immunity in inflammatory bowel disease].
Onizawa M; Ma A; Watanabe M
Nihon Rinsho; 2012 Feb; 70 Suppl 1():91-5. PubMed ID: 23126073
[No Abstract] [Full Text] [Related]
33. TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota.
Ihara S; Hirata Y; Koike K
J Gastroenterol; 2017 Jul; 52(7):777-787. PubMed ID: 28534191
[TBL] [Abstract][Full Text] [Related]
34. Innate antimicrobial immunity in inflammatory bowel diseases.
Beisner J; Stange EF; Wehkamp J
Expert Rev Clin Immunol; 2010 Sep; 6(5):809-18. PubMed ID: 20828289
[TBL] [Abstract][Full Text] [Related]
35. Effects of early environment on mucosal immunologic homeostasis, subsequent immune responses and disease outcome.
Ogra PL; Welliver RC
Nestle Nutr Workshop Ser Pediatr Program; 2008; 61():145-81. PubMed ID: 18196951
[TBL] [Abstract][Full Text] [Related]
36. Intestinal dendritic cells.
Schiavi E; Smolinska S; O'Mahony L
Curr Opin Gastroenterol; 2015 Mar; 31(2):98-103. PubMed ID: 25651073
[TBL] [Abstract][Full Text] [Related]
37. Innate and adaptive mechanisms to control [corrected] pathological intestinal inflammation.
Kelsall BL
J Pathol; 2008 Jan; 214(2):242-59. PubMed ID: 18161750
[TBL] [Abstract][Full Text] [Related]
38. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.
Ekmekciu I; von Klitzing E; Fiebiger U; Neumann C; Bacher P; Scheffold A; Bereswill S; Heimesaat MM
Front Cell Infect Microbiol; 2017; 7():167. PubMed ID: 28529928
[TBL] [Abstract][Full Text] [Related]
39. Role of mucosal T-cell-generated cytokines in epithelial cell injury.
Targan SR; Deem RL; Shanahan F
Immunol Res; 1991; 10(3-4):472-8. PubMed ID: 1955774
[No Abstract] [Full Text] [Related]
40. The proportion of CD40+ mucosal macrophages is increased in inflammatory bowel disease whereas CD40 ligand (CD154)+ T cells are relatively decreased, suggesting differential modulation of these costimulatory molecules in human gut lamina propria.
Carlsen HS; Yamanaka T; Scott H; Rugtveit J; Brandtzaeg P
Inflamm Bowel Dis; 2006 Nov; 12(11):1013-24. PubMed ID: 17075342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
